203 related articles for article (PubMed ID: 29987108)
1. AT
Lange C; Sommerfeld M; Namsolleck P; Kintscher U; Unger T; Kaschina E
Hypertension; 2018 Sep; 72(3):e20-e29. PubMed ID: 29987108
[TBL] [Abstract][Full Text] [Related]
2. Telmisartan prevents aneurysm progression in the rat by inhibiting proteolysis, apoptosis and inflammation.
Kaschina E; Schrader F; Sommerfeld M; Kemnitz UR; Grzesiak A; Krikov M; Unger T
J Hypertens; 2008 Dec; 26(12):2361-73. PubMed ID: 19008714
[TBL] [Abstract][Full Text] [Related]
3. AT2R stimulation with C21 prevents arterial stiffening and endothelial dysfunction in the abdominal aorta from mice fed a high-fat diet.
González-Blázquez R; Alcalá M; Cárdenas-Rebollo JM; Viana M; Steckelings UM; Boisvert WA; Unger T; Fernández-Alfonso MS; Somoza B; Gil-Ortega M
Clin Sci (Lond); 2021 Dec; 135(24):2763-2780. PubMed ID: 34854902
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin type 2 receptor agonist compound 21 reduces vascular injury and myocardial fibrosis in stroke-prone spontaneously hypertensive rats.
Rehman A; Leibowitz A; Yamamoto N; Rautureau Y; Paradis P; Schiffrin EL
Hypertension; 2012 Feb; 59(2):291-9. PubMed ID: 22184324
[TBL] [Abstract][Full Text] [Related]
5. Direct angiotensin II type 2 receptor stimulation in Nω-nitro-L-arginine-methyl ester-induced hypertension: the effect on pulse wave velocity and aortic remodeling.
Paulis L; Becker ST; Lucht K; Schwengel K; Slavic S; Kaschina E; Thöne-Reineke C; Dahlöf B; Baulmann J; Unger T; Steckelings UM
Hypertension; 2012 Feb; 59(2):485-92. PubMed ID: 22215717
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin AT2-receptor stimulation improves survival and neurological outcome after experimental stroke in mice.
Schwengel K; Namsolleck P; Lucht K; Clausen BH; Lambertsen KL; Valero-Esquitino V; Thöne-Reineke C; Müller S; Widdop RE; Denton KM; Horiuchi M; Iwai M; Boato F; Dahlöf B; Hallberg A; Unger T; Steckelings UM
J Mol Med (Berl); 2016 Aug; 94(8):957-66. PubMed ID: 26983606
[TBL] [Abstract][Full Text] [Related]
7. The Effect of a Nonpeptide Angiotensin II Type 2 Receptor Agonist, Compound 21, on Aortic Aneurysm Growth in a Mouse Model of Marfan Syndrome.
Verbrugghe P; Verhoeven J; Clijsters M; Vervoort D; Schepens J; Meuris B; Herijgers P
J Cardiovasc Pharmacol; 2018 Apr; 71(4):215-222. PubMed ID: 29300219
[TBL] [Abstract][Full Text] [Related]
8. C21 preserves endothelial function in the thoracic aorta from DIO mice: role for AT2, Mas and B2 receptors.
González-Blázquez R; Alcalá M; Fernández-Alfonso MS; Steckelings UM; Lorenzo MP; Viana M; Boisvert WA; Unger T; Gil-Ortega M; Somoza B
Clin Sci (Lond); 2021 May; 135(9):1145-1163. PubMed ID: 33899912
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of experimental abdominal aortic aneurysm in a rat model by the angiotensin receptor blocker valsartan.
Fujiwara Y; Shiraya S; Miyake T; Yamakawa S; Aoki M; Makino H; Nishimura M; Morishita R
Int J Mol Med; 2008 Dec; 22(6):703-8. PubMed ID: 19020766
[TBL] [Abstract][Full Text] [Related]
10. A peptide antagonist of thrombospondin-1 promotes abdominal aortic aneurysm progression in the angiotensin II-infused apolipoprotein-E-deficient mouse.
Krishna SM; Seto SW; Jose RJ; Biros E; Moran CS; Wang Y; Clancy P; Golledge J
Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):389-98. PubMed ID: 25524772
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin type 2 receptor stimulation ameliorates left ventricular fibrosis and dysfunction via regulation of tissue inhibitor of matrix metalloproteinase 1/matrix metalloproteinase 9 axis and transforming growth factor β1 in the rat heart.
Lauer D; Slavic S; Sommerfeld M; Thöne-Reineke C; Sharkovska Y; Hallberg A; Dahlöf B; Kintscher U; Unger T; Steckelings UM; Kaschina E
Hypertension; 2014 Mar; 63(3):e60-7. PubMed ID: 24379181
[TBL] [Abstract][Full Text] [Related]
12. Role of interleukin-10 in the neuroprotective effect of the Angiotensin Type 2 Receptor agonist, compound 21, after ischemia/reperfusion injury.
Fouda AY; Pillai B; Dhandapani KM; Ergul A; Fagan SC
Eur J Pharmacol; 2017 Mar; 799():128-134. PubMed ID: 28192099
[TBL] [Abstract][Full Text] [Related]
13. Long-Term Effects of the Abdominal Aortic Aneurysm Model in Rabbits Prepared by Pancreatic Elastase Combined With Angiotensin II.
Chen Q; Nie MX; Zhao QM
Vasc Endovascular Surg; 2019 Jan; 53(1):35-41. PubMed ID: 30373483
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin AT₂ receptor stimulation inhibits early renal inflammation in renovascular hypertension.
Matavelli LC; Huang J; Siragy HM
Hypertension; 2011 Feb; 57(2):308-13. PubMed ID: 21189405
[TBL] [Abstract][Full Text] [Related]
15. Activation of angiotensin II type-2 receptor protects against cigarette smoke-induced COPD.
Mei D; Tan WSD; Liao W; Heng CKM; Wong WSF
Pharmacol Res; 2020 Nov; 161():105223. PubMed ID: 33017650
[TBL] [Abstract][Full Text] [Related]
16. Oral administration of diferuloylmethane (curcumin) suppresses proinflammatory cytokines and destructive connective tissue remodeling in experimental abdominal aortic aneurysms.
Parodi FE; Mao D; Ennis TL; Pagano MB; Thompson RW
Ann Vasc Surg; 2006 May; 20(3):360-8. PubMed ID: 16779518
[TBL] [Abstract][Full Text] [Related]
17. Suppression of experimental abdominal aortic aneurysm in a rat model by the phosphodiesterase 3 inhibitor cilostazol.
Zhang Q; Huang JH; Xia RP; Duan XH; Jiang YB; Jiang Q; Sun WJ
J Surg Res; 2011 May; 167(2):e385-93. PubMed ID: 21392796
[TBL] [Abstract][Full Text] [Related]
18. AT2R agonist NP-6A4 mitigates aortic stiffness and proteolytic activity in mouse model of aneurysm.
Sharma N; Belenchia AM; Toedebusch R; Pulakat L; Hans CP
J Cell Mol Med; 2020 Jul; 24(13):7393-7404. PubMed ID: 32420690
[TBL] [Abstract][Full Text] [Related]
19. The Selective Angiotensin II Type 2 Receptor Agonist Compound 21 Reduces Abdominal Adhesions in Mice.
Boudreau C; LeVatte T; Jones C; Gareau A; Legere S; Bezuhly M
J Surg Res; 2020 Dec; 256():231-242. PubMed ID: 32711180
[TBL] [Abstract][Full Text] [Related]
20. Compound 21, a selective agonist of angiotensin AT2 receptors, prevents endothelial inflammation and leukocyte adhesion in vitro and in vivo.
Sampson AK; Irvine JC; Shihata WA; Dragoljevic D; Lumsden N; Huet O; Barnes T; Unger T; Steckelings UM; Jennings GL; Widdop RE; Chin-Dusting JP
Br J Pharmacol; 2016 Feb; 173(4):729-40. PubMed ID: 25560767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
